Esperion gains after Piper Sandler initiates with 'overweight' rating
Shares of drug developer Esperion Therapeutics ESPR.O gain 1.4% to $3.22 premarket
Piper Sandler initiates with "overweight" rating, sets PT at $9, among the highest on Wall Street
Says company's bempedoic acid franchise (Nexletol and Nexlizet) for hypercholesterolemia and cardiovascular disease risk well-positioned for sales expansion
A broad label, evolving clinical practice guidelines, and wide payer access are supporting factors; risk/reward profile attractive - Piper Sandler
Brokerage also expects peak U.S. sales to exceed $650 million, complemented by a notable ex-U.S. royalty stream
Out of 8 analysts that cover stock, six rate "strong buy" or "buy", one rates "hold" and one "sell" - data compiled by LSEG
ESPR stock up about 44% YTD, till last close
Related Articles
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital ba
Cathie Wood Predicts Bitcoin Has Bottomed. Is Now The Best Time to Buy? How to Buy BTC?
Purchasing Bitcoin is generally divided into three stages: pre-transaction, during transaction, and post-transaction. Each stage requires careful attention, as losses can easily arise from operational errors, pitfalls, and other factors.
Musk’s Next Ambition: Building a Space-Based AI Data Center
TradingKey - Musk has long resisted the idea of taking SpaceX public. After the Tesla take-private drama and the resulting SEC penalties (which cost him the chairmanship), he’s been wary of public market entanglements. But something’s changed—and fast.
Gold Price Steady Climb and the Sudden Surge of Silver and Copper: Will Their Bull Run Extend Into 2026?
Dow Jones Market Data shows this marks the first time since 1980all three metals—gold, silver, and copper—simultaneously refreshed their all-time highs in the same year. Will this rally extend into 2026?
